Epoch Investment Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67.7M Buy
140,959
+112,001
+387% +$57.3M 0.41% 96
2025
Q4
$16.3M Sell
28,958
-96,743
-77% -$54.9M 0.09% 187
2025
Q3
$64.6M Sell
125,701
-319,530
-72% -$140M 0.36% 108
2025
Q2
$140M Buy
445,231
+45,435
+11% +$13.6M 0.72% 42
2025
Q1
$122M Sell
399,796
-38,304
-9% -$12.9M 0.63% 59
2024
Q4
$146M Buy
438,100
+21,881
+5% +$7.42M 0.71% 38
2024
Q3
$139M Buy
416,219
+10,504
+3% +$3.99M 0.62% 48
2024
Q2
$167M Sell
405,715
-731
-0.2% -$289K 0.76% 36
2024
Q1
$164M Buy
406,446
+53,983
+15% +$19M 0.73% 39
2023
Q4
$108M Buy
352,463
+159,144
+82% +$43M 0.49% 59
2023
Q3
$46.8M Sell
193,319
-12,611
-6% -$3.23M 0.3% 119
2023
Q2
$49.5M Sell
205,930
-22,881
-10% -$4.75M 0.29% 124
2023
Q1
$43M Sell
228,811
-35,004
-13% -$7.24M 0.26% 138
2022
Q4
$56M Sell
263,815
-56,931
-18% -$11.4M 0.33% 101
2022
Q3
$50.4M Buy
320,746
+22,598
+8% +$3.61M 0.33% 107
2022
Q2
$44.6M Buy
298,148
+19,685
+7% +$2.85M 0.26% 135
2022
Q1
$45.6M Buy
278,463
+33,056
+13% +$5.45M 0.22% 141
2021
Q4
$53.4M Sell
245,407
-2,046
-0.8% -$428K 0.27% 132
2021
Q3
$46.8M Buy
247,453
+7,203
+3% +$1.31M 0.26% 124
2021
Q2
$42.4M Buy
240,250
+33,634
+16% +$5.8M 0.23% 133
2021
Q1
$33.9M Buy
+206,616
New +$31.6M 0.16% 158

Other funds holding MEDP

Epoch Investment Partners's MEDP Position: Q1 2026 in Review

Epoch Investment Partners increased its Medpace (MEDP) stake by 387% in Q1 2026, buying an estimated $57.3M and bringing the position to 140,959 shares worth $67.7M. The position accounts for 0.41% of the portfolio, ranked #96.

Epoch Investment Partners first reported a position in MEDP in Q1 2021 and has held it in 21 quarters since. The position peaked at $167M in Q2 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Epoch Investment Partners held 140,959 shares of Medpace worth $67.7M as of Q1 2026.
  • Epoch Investment Partners bought 112,001 Medpace shares in Q1 2026, an estimated $57.3M.
  • Medpace made up 0.41% of Epoch Investment Partners's portfolio in Q1 2026, its #96 holding.
  • Epoch Investment Partners first reported a position in Medpace in Q1 2021 and has held it in 21 quarters since.
  • Epoch Investment Partners's Medpace position peaked at $167M in Q2 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Epoch Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.